reimburs
price
highest
patent
origin
brand
product
undersurveillanc
offpat
origin
brand
product
price
median
price
top
industri
countri
follow
nonundersurveillanc
offpat
origin
brand
product
price
median
price
top
industri
countri
bioavailabilitybioequival
babe
gener
drug
perform
babe
studi
price
origin
brand
product
nonbab
gener
price
origin
brand
product
babe
gener
subsequ
reimburs
price
product
list
pharmaceut
benefit
scheme
pb
establish
bureau
nation
health
insur
bnhi
adjust
gradual
later
year
earlier
stage
price
adjust
base
price
intern
product
exist
product
interbrand
comparison
bnhi
taiwan
began
conduct
market
price
volum
survey
price
adjust
price
adjust
implement
april
bnhi
adjust
individu
product
reimburs
price
accord
follow
equat
wap
p
old
reimburs
price
adjust
wap
p
old
reimburs
price
adjust
follow
p
new
wap
p
old
r
p
old
reimburs
price
individu
product
adjust
p
new
new
reimburs
price
individu
product
adjust
r
access
profit
margin
physician
impos
bnhi
see
tabl
sinc
price
adjust
implement
april
reimburs
price
patent
offpat
product
adjust
bnhi
accord
differ
strategi
follow
patent
drug
includ
drug
qualifi
market
exclus
taiwan
individu
drug
price
still
adjust
base
equat
rzone
shown
tabl
offpat
drug
drug
without
intellectu
right
argument
faryear
drug
principl
gener
group
appli
first
group
drug
ident
activ
ingredi
content
strength
subsequ
product
group
classifi
three
class
origin
brand
gener
biolog
product
bioequivalentbioavail
babe
test
perform
b
babe
product
outsid
first
class
c
drug
babe
test
conduct
product
within
group
class
group
weight
averag
markettrad
price
gwap
calcul
product
volum
price
purchas
physician
obtain
market
survey
price
offpat
drug
adjust
also
accord
equat
modif
part
wap
replac
gwap
equat
unless
gwap
larger
wap
reimburs
price
class
drug
ie
origin
brand
offpat
drug
calcul
use
time
valu
gwap
equat
rzone
shown
tabl
enalapril
angiotensinconvert
enzym
inhibitor
acei
defin
patent
drug
bnhi
therefor
price
adjust
drug
accord
individu
product
weight
averag
market
trade
price
wap
rzone
drug
set
well
sinc
becam
offpat
product
thu
price
adjust
brand
drug
accord
group
drug
group
weight
averag
market
trade
price
gwap
rzone
drug
instead
individu
drug
weight
averag
market
trade
price
wap
wap
weight
averag
market
trade
price
calcul
market
survey
st
rd
time
price
adjust
p
new
drug
entri
price
p
reimburs
price
st
rd
time
price
adjust
p
new
reimburs
price
price
adjust
rzone
access
profit
margin
physician
set
st
rd
price
adjust
stepwis
price
adjust
set
tabl
b
show
lower
reimburs
price
decreas
profit
physician
profit
reduct
nt
rzone
reason
zone
weight
averag
market
trade
price
impos
bnhi
allow
access
profit
margin
physician
price
adjust
enalapril
accord
wap
sinc
enalapril
turn
offpat
product
price
adjust
enalapril
accord
gwap
pa
price
adjust
wap
weight
averag
market
trade
price
gwap
group
weight
averag
market
trade
price
nt
new
taiwan
dollar
exchang
rate
nt
us
june
p
old
reimburs
price
price
adjust
p
new
reimburs
price
price
adjust
p
reduct
reduct
p
old
p
new
profit
old
profit
physician
price
adjust
ie
p
old
minu
wap
p
old
minu
gwap
profit
new
profit
physician
price
adjust
ie
p
new
minu
wap
p
new
minu
gwap
profit
reduct
reduct
profit
old
profit
new
price
adjust
implement
april
price
adjust
implement
april
price
adjust
implement
march
price
adjust
implement
novemb
price
adjust
implement
septemb
hypothes
exampl
display
throughout
stepwis
price
adjust
differ
reimburs
price
market
trade
price
ie
profit
physician
narrow
also
import
find
patent
enalapril
turn
offpat
enalapril
time
implement
reimburs
price
drug
adjust
accord
lower
gwap
well
smaller
rzone
compar
wap
rzone
therefor
reduct
reimburs
price
larger
profit
margin
physician
significantli
squeez
